These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 29226890)
21. Predictors for functionally significant in-stent restenosis: an integrated analysis using coronary angiography, IVUS, and myocardial perfusion imaging. Kang SJ; Cho YR; Park GM; Ahn JM; Han SB; Lee JY; Kim WJ; Park DW; Lee SW; Kim YH; Lee CW; Park SW; Mintz GS; Park SJ JACC Cardiovasc Imaging; 2013 Nov; 6(11):1183-90. PubMed ID: 24229771 [TBL] [Abstract][Full Text] [Related]
22. Serum concentration of insulin-like growth factor-I, but not tumor necrosis factor-alpha, measured twelve months after stenting of the infarct-related artery, is associated with in-stent restenosis. Szkodzinski J; Hudzik B; Romanowski W; Wilczek K; Danikiewicz A; Gasior M; Polonski L; Zubelewicz-Szkodzinska B J Biol Regul Homeost Agents; 2010; 24(2):149-56. PubMed ID: 20487628 [TBL] [Abstract][Full Text] [Related]
23. Comparison of outcomes after percutaneous coronary intervention among different coronary subsets (stable and unstable angina pectoris and ST-segment and non-ST-segment myocardial infarction). Loh JP; Pendyala LK; Kitabata H; Torguson R; Omar A; Minha S; Chen F; Satler LF; Pichard AD; Waksman R Am J Cardiol; 2014 Jun; 113(11):1794-801. PubMed ID: 24837256 [TBL] [Abstract][Full Text] [Related]
24. Elevated Levels of Very Low-density Lipoprotein Cholesterol Independently Associated with In-stent Restenosis in Diabetic Patients after Drug-eluting Stent Implantation. Qin Z; Zheng FW; Zeng C; Zhou K; Geng Y; Wang JL; Li YP; Ji QW; Zhou YJ Chin Med J (Engl); 2017 Oct; 130(19):2326-2332. PubMed ID: 28836572 [TBL] [Abstract][Full Text] [Related]
25. Angiotensin type 1 receptor A1166C gene polymorphism is associated with endothelial dysfunction and in-stent restenosis after percutaneous coronary intervention. Li Y; Chen F; Zhang X; Gao Y; Wu C; Li H; Zhang Y Int J Clin Exp Pathol; 2015; 8(6):7350-7. PubMed ID: 26261635 [TBL] [Abstract][Full Text] [Related]
26. Resistant in-stent restenosis in the drug eluting stent era. Theodoropoulos K; Mennuni MG; Dangas GD; Meelu OA; Bansilal S; Baber U; Sartori S; Kovacic JC; Moreno PR; Sharma SK; Mehran R; Kini AS Catheter Cardiovasc Interv; 2016 Nov; 88(5):777-785. PubMed ID: 27184223 [TBL] [Abstract][Full Text] [Related]
27. Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up. Zhao LP; Xu WT; Wang L; Li H; Shao CL; Gu HB; Chan SP; Xu HF; Yang XJ Coron Artery Dis; 2015 Jan; 26(1):5-10. PubMed ID: 25211654 [TBL] [Abstract][Full Text] [Related]
29. Acute coronary syndrome - a frequent clinical manifestation of bare metal in-stent restenosis. Drozd J; Wójcik J; Małek R; Korona B; Zapolski T; Wysokiński A Kardiol Pol; 2010 Jun; 68(6):637-45. PubMed ID: 20806192 [TBL] [Abstract][Full Text] [Related]
30. Independent predictors of in-stent restenosis after drug-eluting stent implantation for ostial right coronary artery lesions. Watanabe Y; Takagi K; Naganuma T; Kawamoto H; Fujino Y; Ishiguro H; Tahara S; Kurita N; Hosawa K; Nakamura S; Nakamura S Int J Cardiol; 2017 Aug; 240():108-113. PubMed ID: 28476515 [TBL] [Abstract][Full Text] [Related]
31. Randomized trial of optimal treatment strategies for in-stent restenosis after drug-eluting stent implantation. Song HG; Park DW; Kim YH; Ahn JM; Kim WJ; Lee JY; Kang SJ; Lee SW; Lee CW; Park SW; Han S; Seong IW; Lee NH; Lee BK; Lee K; Lee SW; Nah DY; Park SJ J Am Coll Cardiol; 2012 Mar; 59(12):1093-100. PubMed ID: 22421303 [TBL] [Abstract][Full Text] [Related]
32. Impact of coronary collateral circulation on angiographic in-stent restenosis in patients with stable coronary artery disease and chronic total occlusion. Yang ZK; Shen Y; Hu J; Zhang Q; Ding FH; Zhang RY; Lu L; Shen WF Int J Cardiol; 2017 Jan; 227():485-489. PubMed ID: 27836292 [TBL] [Abstract][Full Text] [Related]
33. Comparison of outcomes after treatment of in-stent restenosis using newer generation drug-eluting stents versus drug-eluting balloon: Patient-level pooled analysis of Korean Multicenter in-Stent Restenosis Registry. Lee JM; Rhee TM; Hahn JY; Hwang D; Park J; Park KW; Kim HL; Kim SH; Chae IH; Doh JH; Jeon KH; Choi YJ; Park JS; Choi SH; Gwon HC; Koo BK; Alfonso F; Kim HS Int J Cardiol; 2017 Mar; 230():181-190. PubMed ID: 28043660 [TBL] [Abstract][Full Text] [Related]
34. The impact of main branch restenosis on long term mortality following drug-eluting stent implantation in patients with de novo unprotected distal left main bifurcation coronary lesions: the Milan and New-Tokyo (MITO) Registry. Takagi K; Ielasi A; Basavarajaiah S; Chieffo A; Shannon J; Godino C; Hasegawa T; Naganuma T; Fujino Y; Latib A; Carlino M; Montorfano M; Nakamura S; Colombo A Catheter Cardiovasc Interv; 2014 Sep; 84(3):341-8. PubMed ID: 24038911 [TBL] [Abstract][Full Text] [Related]
35. Impact of hypertension on postreperfusion left ventricular recovery in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease. Vaicekavičius E; Vasiliauskas D; Navickas R; Milvidaitė I; Unikas R; Venclovienė J; Kubilius R Medicina (Kaunas); 2015; 51(1):38-45. PubMed ID: 25744774 [TBL] [Abstract][Full Text] [Related]
36. Association of the Endothelial Nitric Oxide Synthase Gene T786C Polymorphism with In-Stent Restenosis in Chinese Han Patients with Coronary Artery Disease Treated with Drug-Eluting Stent. Zeng WP; Zhang R; Li R; Luo JF; Hu XF PLoS One; 2017; 12(1):e0170964. PubMed ID: 28129392 [TBL] [Abstract][Full Text] [Related]
37. Mesh-covered embolic protection stent implantation in ST-segment-elevation myocardial infarction: final 1-year clinical and angiographic results from the MGUARD for acute ST elevation reperfusion trial. Dudek D; Dziewierz A; Brener SJ; Abizaid A; Merkely B; Costa RA; Bar E; Rakowski T; Kornowski R; Dressler O; Abizaid A; Silber S; Stone GW Circ Cardiovasc Interv; 2015 Feb; 8(2):e001484. PubMed ID: 25603802 [TBL] [Abstract][Full Text] [Related]
38. The Relationship Between Lymphocyte-to-Monocyte Ratio and Bare-Metal Stent In-Stent Restenosis in Patients With Stable Coronary Artery Disease. Murat SN; Yarlioglues M; Celik IE; Kurtul A; Duran M; Kilic A; Oksuz F Clin Appl Thromb Hemost; 2017 Apr; 23(3):235-240. PubMed ID: 26759373 [TBL] [Abstract][Full Text] [Related]